GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County...( ATLANTA June 18 /- GeoVax Labs Inc. ...)

ATLANTA, June 18 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by the HIV-1 (Human Immunodeficiency Virus), and other infectious agents, announced today that it signed a proposal to discuss a cooperative arrangement with Cook County Board President Todd H. Stroger and the Commissioner's of Cook County; the Cook County Health and Hospitals Systems Board ("Health System"); and the Ruth M. Rothstein's CORE Center's Foundation, ("Foundation"), that was founded by Cook County, Illinois and Rush University Medical Center.

Robert T. McNally, President of GeoVax noted, "The proposed arrangement with Cook County through the Health System and its CORE Foundation has the potential to advance the fight against HIV/AIDS by accelerating the clinical trials of the DNA/MVA and MVA/MVA vaccines developed by GeoVax scientists, in collaboration with scientists at Emory University; the Center for Disease Control; and the U.S. National Institutes of Health ("the Vaccines")."

Cook County Board President Todd H. Stroger said, "We hope this ground-breaking proposal, which is dedicated to addressing the need to help eradicate the HIV/AIDS virus, will extend the opportunity for the residents of Cook County and the surrounding region to participate in clinical trials of vaccines with the potential to protect against HIV/AIDS disease." President Stroger added, "This partnership carries out the mission set forth by our Health and Hospitals Systems in providing state-of-the-art quality urgent healthcare to people. It will also assist in accelerating GeoVax's vaccine program for treatment of patients infected with the HIV virus. We must always be prepared to adapt to the ever changing needs of society while continuing to contribute to the overall health and wellness of our world."

The propos
'/>"/>